## Abstract Magnetic resonance spectroscopic imaging (MRSI) has proven to be a powerful tool for the metabolic characterization of prostate cancer in patients before and following therapy. The metabolites that are of particular interest are citrate and choline because an increased choline‐to‐citrat
Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging
✍ Scribed by Joan C. Vilanova; Joaquim Barceló
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 593 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0942-8925
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Purpose: To differentiate prostate carcinoma from healthy peripheral zone and central gland using quantitative dynamic contrast-enhanced (dce) magnetic resonance (mr) imaging and two-dimensional (1)h mr spectroscopic imaging (mrsi) combined into one clinical protocol. ## Materials and methods:
Combined MRI and 3D spectroscopic imaging (MRI/3D-MRSI) was used to study the metabolic effects of hormone-deprivation therapy in 65 prostate cancer patients, who underwent either short, intermediate, or long-term therapy, compared to 30 untreated control patients. There was a significant time-depen
## Abstract Proton magnetic resonance spectroscopic imaging (MRSI) of the prostate has been described at 1.5 T and 3 T as a means of localizing prostate cancers with high sensitivity and specificity. This technique could be improved by increasing the field strength further; however, it has not been